PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR)

Philip Kranz(University of Duisburg-Essen), Fabian Neumann(University of Duisburg-Essen), Alexandra Wolf(University of Duisburg-Essen), Fabian Classen(University of Duisburg-Essen), Mosche Pompsch(University of Duisburg-Essen), Tobias Ocklenburg(University of Duisburg-Essen), J Baumann(University of Duisburg-Essen), Kirsten Janke(University of Duisburg-Essen), Melanie Baumann(University of Duisburg-Essen), Kirsten Goepelt(University of Duisburg-Essen), Helena Riffkin(University of Duisburg-Essen), Eric Metzen(University of Duisburg-Essen), Ulf Brockmeier(University of Duisburg-Essen)
Cell Death and Disease
August 10, 2017
Cited by 122Open Access
Full Text

Abstract

Endoplasmic reticulum (ER) stress leads to activation of the unfolded protein response (UPR) that results in transient suppression of protein translation to allow recovery but leads to cell death when stress cannot be resolved. Central to initiation of the UPR is the activation of the ER transmembrane kinase protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). Here we report that the thiol oxidoreductase ERp57 and protein disulfide isomerase-A1 (PDI), which belong to the same family of luminal ER oxidoreductases, have strikingly opposing roles in the regulation of PERK function. In HCT116 colon carcinoma cells, lentiviral depletion of ERp57 resulted in oxidation of PDI and activation of PERK, whereas depletion or chemical inhibition of PDI reduced PERK signaling and sensitized the cancer cells to hypoxia and ER stress. We conclude that oxidized PDI acts as a PERK activator, whereas ERp57 keeps PDI in a reduced state in the absence of ER stress. Thus, our study defines a new interface between metabolic redox signaling and PERK-dependent activation of the UPR and has the potential to influence future cancer therapies that target PERK signaling.


Related Papers

No related papers found

Powered by citation graph analysis